Inspira Technologies OXY B.H.N. Ltd

IINN Nasdaq CIK: 0001837493

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type other
SEC Category Non-accelerated filerEmerging growth company
State of Incorporation Israel
Business Address HATIDHAR 2, RA'ANANA, L3, 4366504
Mailing Address HATIDHAR 2, RA'ANANA, L3, 4366504
Phone 972-9-9664488
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

$8.07M
Total Assets
$5.11M
Cash & Equivalents
$-0.45
EPS

Recent SEC Filings

Form Type Date Filed Document
6-K Foreign company current report April 6, 2026 View on SEC
6-K Foreign company current report April 6, 2026 View on SEC
6-K Foreign company current report March 31, 2026 View on SEC
6-K Foreign company current report March 26, 2026 View on SEC
6-K Foreign company current report March 26, 2026 View on SEC
20-F Foreign company annual report March 26, 2026 View on SEC
3 Initial insider ownership report March 24, 2026 View on SEC
3 Initial insider ownership report March 19, 2026 View on SEC
3 Initial insider ownership report March 19, 2026 View on SEC
3 Initial insider ownership report March 19, 2026 View on SEC

Annual Reports

20-F March 26, 2026
  • FDA clearance and Israeli Ministry of Health approval for the INSPIRA ART100 system received in 2024.
  • Successful transition to commercialization with the first shipment of ART100 to Westchester Medical Center.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.